FICHA FARMACOLÓGICA de Perflutren. Contiene la Monografía en distintos idiomas (de la Comunidad Económica Europea), así como la discusión científica que sustenta su aprobación terapéutica. Para acceder a la monografía en idioma español, hacer doble clik en la sigla (es) en la fila que se sitúa más abajo del centro de la página oficial. Cerasale. ABRIL 09, 2009.
abrir aquí:
EPARs for authorised medicinal products for human use - Luminity
Active Substance
Perflutren
International Nonproprietary Name or Common Name
Perflutren
Pharmaco-therapeutic Group
Ultrasound contrast media, microspheres of phospholipids
ATC Code
V08DA04
Therapeutic Indication:
This medicinal product is for diagnostic use only.
Luminity is an ultrasound contrast-enhancing agent for use in patients in whom non-contrast echocardiography was suboptimal (suboptimal is considered to indicate that at least two of six segments in the 4- or 2-chamber view of the ventricular border were not evaluable) and who have suspected or established coronary artery disease, to provide opacification of cardiac chambers and improvement of left ventricular endocardial border delineation at both rest and stress.
Date of issue of Marketing Authorisation valid throughout the European Union
20 September 2006
.png)
No hay comentarios:
Publicar un comentario